

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 8.47172639 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.31205709 |
| 3 | proteasome assembly (GO:0043248) | 5.17142552 |
| 4 | viral transcription (GO:0019083) | 5.13688704 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.93353924 |
| 6 | translational termination (GO:0006415) | 4.91683463 |
| 7 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.84404805 |
| 8 | estrogen biosynthetic process (GO:0006703) | 4.82317151 |
| 9 | ATP synthesis coupled proton transport (GO:0015986) | 4.61075709 |
| 10 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.61075709 |
| 11 | translational elongation (GO:0006414) | 4.52707881 |
| 12 | regulation of mitochondrial translation (GO:0070129) | 4.45164969 |
| 13 | ribosomal small subunit biogenesis (GO:0042274) | 4.38534018 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.36493420 |
| 15 | cotranslational protein targeting to membrane (GO:0006613) | 4.28004723 |
| 16 | protein targeting to ER (GO:0045047) | 4.24713100 |
| 17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.20460706 |
| 18 | protein complex biogenesis (GO:0070271) | 4.18346462 |
| 19 | protein targeting to mitochondrion (GO:0006626) | 4.08759012 |
| 20 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.06192825 |
| 21 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.05966079 |
| 22 | cellular protein complex disassembly (GO:0043624) | 4.05617992 |
| 23 | translational initiation (GO:0006413) | 4.02300976 |
| 24 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.01663145 |
| 25 | establishment of protein localization to mitochondrion (GO:0072655) | 4.00268170 |
| 26 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.98107781 |
| 27 | NADH dehydrogenase complex assembly (GO:0010257) | 3.98107781 |
| 28 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.98107781 |
| 29 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.96589592 |
| 30 | viral life cycle (GO:0019058) | 3.91477745 |
| 31 | base-excision repair, AP site formation (GO:0006285) | 3.89211448 |
| 32 | GDP-mannose metabolic process (GO:0019673) | 3.86921673 |
| 33 | chaperone-mediated protein transport (GO:0072321) | 3.85544258 |
| 34 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.80030982 |
| 35 | protein maturation by protein folding (GO:0022417) | 3.79129678 |
| 36 | translation (GO:0006412) | 3.77938137 |
| 37 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.77712883 |
| 38 | negative regulation of ligase activity (GO:0051352) | 3.77712883 |
| 39 | formation of translation preinitiation complex (GO:0001731) | 3.71118173 |
| 40 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.69843944 |
| 41 | maturation of SSU-rRNA (GO:0030490) | 3.69743748 |
| 42 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.68330683 |
| 43 | respiratory chain complex IV assembly (GO:0008535) | 3.66362334 |
| 44 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.65960567 |
| 45 | ribosomal large subunit biogenesis (GO:0042273) | 3.62008825 |
| 46 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.60920120 |
| 47 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.60920120 |
| 48 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.58288197 |
| 49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.56962680 |
| 50 | oxidative phosphorylation (GO:0006119) | 3.56449918 |
| 51 | protein complex disassembly (GO:0043241) | 3.55515614 |
| 52 | tRNA methylation (GO:0030488) | 3.54706551 |
| 53 | GMP metabolic process (GO:0046037) | 3.53509155 |
| 54 | respiratory electron transport chain (GO:0022904) | 3.52790379 |
| 55 | electron transport chain (GO:0022900) | 3.51981952 |
| 56 | macromolecular complex disassembly (GO:0032984) | 3.50840491 |
| 57 | negative regulation of microtubule polymerization (GO:0031115) | 3.50626026 |
| 58 | iron-sulfur cluster assembly (GO:0016226) | 3.50584699 |
| 59 | metallo-sulfur cluster assembly (GO:0031163) | 3.50584699 |
| 60 | sequestering of actin monomers (GO:0042989) | 3.50293148 |
| 61 | protein insertion into membrane (GO:0051205) | 3.48848501 |
| 62 | protein localization to mitochondrion (GO:0070585) | 3.48365762 |
| 63 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.47117973 |
| 64 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.46107713 |
| 65 | cytochrome complex assembly (GO:0017004) | 3.39626782 |
| 66 | NIK/NF-kappaB signaling (GO:0038061) | 3.38967060 |
| 67 | positive regulation of prostaglandin secretion (GO:0032308) | 3.37173293 |
| 68 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.36345360 |
| 69 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.35425614 |
| 70 | UV protection (GO:0009650) | 3.34035111 |
| 71 | de novo protein folding (GO:0006458) | 3.30551511 |
| 72 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.29105320 |
| 73 | termination of RNA polymerase III transcription (GO:0006386) | 3.29105320 |
| 74 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.27869441 |
| 75 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.27869441 |
| 76 | de novo posttranslational protein folding (GO:0051084) | 3.25878656 |
| 77 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.24309113 |
| 78 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.24309113 |
| 79 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.24309113 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.23041469 |
| 81 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.22763970 |
| 82 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.22490310 |
| 83 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.20986308 |
| 84 | spliceosomal snRNP assembly (GO:0000387) | 3.17857554 |
| 85 | L-methionine salvage (GO:0071267) | 3.17831787 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 3.17831787 |
| 87 | amino acid salvage (GO:0043102) | 3.17831787 |
| 88 | cellular component biogenesis (GO:0044085) | 3.15034593 |
| 89 | response to misfolded protein (GO:0051788) | 3.14049794 |
| 90 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.13039595 |
| 91 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.13039595 |
| 92 | nucleoside salvage (GO:0043174) | 3.10292765 |
| 93 | deoxyribose phosphate catabolic process (GO:0046386) | 3.09328226 |
| 94 | positive thymic T cell selection (GO:0045059) | 3.08813173 |
| 95 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.07276006 |
| 96 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.06710180 |
| 97 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.05035771 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 3.04160134 |
| 99 | pseudouridine synthesis (GO:0001522) | 3.01909614 |
| 100 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.01876579 |
| 101 | positive regulation of ligase activity (GO:0051351) | 3.01106304 |
| 102 | response to peptidoglycan (GO:0032494) | 3.00442249 |
| 103 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.98135410 |
| 104 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.97527704 |
| 105 | protein targeting to membrane (GO:0006612) | 2.97344684 |
| 106 | deoxyribonucleotide catabolic process (GO:0009264) | 2.95873705 |
| 107 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.95639676 |
| 108 | regulation of protein heterodimerization activity (GO:0043497) | 2.95613413 |
| 109 | DNA strand elongation (GO:0022616) | 2.95485429 |
| 110 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.94831567 |
| 111 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.94723426 |
| 112 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.94110116 |
| 113 | protein deneddylation (GO:0000338) | 2.93812270 |
| 114 | anterograde synaptic vesicle transport (GO:0048490) | 2.92701069 |
| 115 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.87893902 |
| 116 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.87385312 |
| 117 | response to pheromone (GO:0019236) | 2.86652795 |
| 118 | amino sugar catabolic process (GO:0046348) | 2.82899433 |
| 119 | GPI anchor biosynthetic process (GO:0006506) | 2.82082247 |
| 120 | immunoglobulin mediated immune response (GO:0016064) | 2.81588134 |
| 121 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.80702952 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77831574 |
| 123 | cellular response to arsenic-containing substance (GO:0071243) | 2.77745578 |
| 124 | negative regulation of interleukin-12 production (GO:0032695) | 2.73917752 |
| 125 | positive regulation of fatty acid transport (GO:2000193) | 2.71313882 |
| 126 | positive regulation of icosanoid secretion (GO:0032305) | 2.67012956 |
| 127 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.66378478 |
| 128 | regulation of B cell apoptotic process (GO:0002902) | 2.63343112 |
| 129 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.60963272 |
| 130 | positive regulation of protein deacetylation (GO:0090312) | 2.58947469 |
| 131 | positive regulation of histone deacetylation (GO:0031065) | 2.58889903 |
| 132 | ncRNA 3-end processing (GO:0043628) | 2.58515502 |
| 133 | opioid receptor signaling pathway (GO:0038003) | 2.57431448 |
| 134 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.56514846 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.55632653 |
| 136 | negative regulation of granulocyte differentiation (GO:0030853) | 2.54067657 |
| 137 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53867919 |
| 138 | positive regulation of T cell apoptotic process (GO:0070234) | 2.53236758 |
| 139 | negative regulation of mast cell activation (GO:0033004) | 2.53106985 |
| 140 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.53085237 |
| 141 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.53085237 |
| 142 | regulation of mast cell degranulation (GO:0043304) | 2.52891036 |
| 143 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52886354 |
| 144 | response to protozoan (GO:0001562) | 2.52844506 |
| 145 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.52209165 |
| 146 | positive regulation of mast cell degranulation (GO:0043306) | 2.51121691 |
| 147 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.51121691 |
| 148 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.50009878 |
| 149 | negative regulation of cell killing (GO:0031342) | 2.50009878 |
| 150 | GPI anchor metabolic process (GO:0006505) | 2.48052869 |
| 151 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.48016900 |
| 152 | lytic vacuole organization (GO:0080171) | 2.47655624 |
| 153 | lysosome organization (GO:0007040) | 2.47655624 |
| 154 | seminiferous tubule development (GO:0072520) | 2.45676514 |
| 155 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.43286875 |
| 156 | polyamine biosynthetic process (GO:0006596) | 2.43142874 |
| 157 | positive T cell selection (GO:0043368) | 2.41744939 |
| 158 | response to acidic pH (GO:0010447) | 2.40524472 |
| 159 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.39913734 |
| 160 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.39749870 |
| 161 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.39701298 |
| 162 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.38571762 |
| 163 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.37979187 |
| 164 | positive regulation of mast cell activation (GO:0033005) | 2.37919645 |
| 165 | regulation of prostaglandin secretion (GO:0032306) | 2.37139188 |
| 166 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.36754099 |
| 167 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.35667026 |
| 168 | toxin transport (GO:1901998) | 2.34739288 |
| 169 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33790480 |
| 170 | regulation of mast cell activation (GO:0033003) | 2.33781723 |
| 171 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.33316705 |
| 172 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.32861269 |
| 173 | cytidine metabolic process (GO:0046087) | 2.32686582 |
| 174 | cytidine catabolic process (GO:0006216) | 2.32686582 |
| 175 | cytidine deamination (GO:0009972) | 2.32686582 |
| 176 | pentose metabolic process (GO:0019321) | 2.32383840 |
| 177 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.31934375 |
| 178 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.31296123 |
| 179 | negative regulation of sodium ion transport (GO:0010766) | 2.30055647 |
| 180 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.26407674 |
| 181 | phagosome maturation (GO:0090382) | 2.25898935 |
| 182 | negative regulation of phagocytosis (GO:0050765) | 2.25453157 |
| 183 | viral protein processing (GO:0019082) | 2.24894894 |
| 184 | defense response to protozoan (GO:0042832) | 2.24667750 |
| 185 | GTP biosynthetic process (GO:0006183) | 2.24211576 |
| 186 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.23132470 |
| 187 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.23132470 |
| 188 | actin nucleation (GO:0045010) | 2.22471405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.39194846 |
| 2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.55330308 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.38609535 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.25076507 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23495927 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.23406864 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.14641729 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07010076 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.04228622 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.99592852 |
| 11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.96840872 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.88882300 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.78259042 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.67381558 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.52483606 |
| 16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.50113120 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.46334473 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.44075926 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.36398926 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.33269857 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.29277557 |
| 22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.28974087 |
| 23 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.25273160 |
| 24 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.21594318 |
| 25 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.18877811 |
| 26 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.08097313 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07939320 |
| 28 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05358709 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.00252588 |
| 30 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.95523306 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90235153 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88606061 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.87716698 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84133625 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83342497 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.82141120 |
| 37 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.79625742 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.78245805 |
| 39 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.77131530 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.75000845 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.74962505 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.73905175 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73174998 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72524877 |
| 45 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.72246020 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.71826764 |
| 47 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.66443638 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66017027 |
| 49 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65847644 |
| 50 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.63345325 |
| 51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.63286459 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.60305436 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.60296009 |
| 54 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58873378 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56736632 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51443964 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.50422066 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49827575 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49786445 |
| 60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49020491 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48901132 |
| 62 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47173994 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45695206 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.45454764 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.45255184 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43725328 |
| 67 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.43572054 |
| 68 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43513972 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39919892 |
| 70 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.38996830 |
| 71 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37683882 |
| 72 | P300_27268052_Chip-Seq_Bcells_Human | 1.36882304 |
| 73 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.36110530 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.35840073 |
| 75 | MYC_22102868_ChIP-Seq_BL_Human | 1.35824392 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35217671 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.34519164 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.34500561 |
| 79 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.32325974 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32219012 |
| 81 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.32199796 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31574527 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31117993 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31101906 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30772906 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30573983 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29535868 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28936891 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.27013635 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.26753954 |
| 91 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.26647866 |
| 92 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.26147730 |
| 93 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24821414 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24319514 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.23763564 |
| 96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.23684186 |
| 97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.22717092 |
| 98 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22710191 |
| 99 | ERA_21632823_ChIP-Seq_H3396_Human | 1.21143706 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.20607683 |
| 101 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19048224 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.18114877 |
| 103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17966588 |
| 104 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.17425194 |
| 105 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16524405 |
| 106 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.16503579 |
| 107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.16360997 |
| 108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16038994 |
| 109 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15792818 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14154604 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.13893175 |
| 112 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.13569646 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13234474 |
| 114 | P68_20966046_ChIP-Seq_HELA_Human | 1.12959701 |
| 115 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12179478 |
| 116 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11786175 |
| 117 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.11730413 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10546769 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.10073741 |
| 120 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09557377 |
| 121 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09354732 |
| 122 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09335606 |
| 123 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09230860 |
| 124 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.09216087 |
| 125 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.08440894 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.08155879 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08150839 |
| 128 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07616614 |
| 129 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.07205166 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06940717 |
| 131 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06764120 |
| 132 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.05406947 |
| 133 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04826647 |
| 134 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04459608 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04364013 |
| 136 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.04155813 |
| 137 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02978699 |
| 138 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02900471 |
| 139 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01342427 |
| 140 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00939174 |
| 141 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00285636 |
| 142 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.00198536 |
| 143 | MAF_26560356_Chip-Seq_TH2_Human | 0.99726066 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98871387 |
| 145 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.98844856 |
| 146 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98532279 |
| 147 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97936781 |
| 148 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97114917 |
| 149 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96093555 |
| 150 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.95829080 |
| 151 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95177935 |
| 152 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94776494 |
| 153 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93744197 |
| 154 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91659806 |
| 155 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90965983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006292_abnormal_olfactory_placode | 3.31600224 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.21351272 |
| 3 | MP0009840_abnormal_foam_cell | 3.16832719 |
| 4 | MP0009379_abnormal_foot_pigmentation | 3.14800574 |
| 5 | MP0003172_abnormal_lysosome_physiology | 3.00496384 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.87623897 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.76767150 |
| 8 | MP0002638_abnormal_pupillary_reflex | 2.74514125 |
| 9 | MP0005451_abnormal_body_composition | 2.71663432 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.67866758 |
| 11 | MP0004858_abnormal_nervous_system | 2.61834442 |
| 12 | MP0003436_decreased_susceptibility_to | 2.58211510 |
| 13 | MP0003303_peritoneal_inflammation | 2.56939253 |
| 14 | MP0003693_abnormal_embryo_hatching | 2.55648392 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.55533134 |
| 16 | MP0003123_paternal_imprinting | 2.40139008 |
| 17 | MP0005084_abnormal_gallbladder_morpholo | 2.31401370 |
| 18 | MP0003329_amyloid_beta_deposits | 2.29311294 |
| 19 | MP0004859_abnormal_synaptic_plasticity | 2.26143904 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 2.23962753 |
| 21 | MP0002736_abnormal_nociception_after | 2.23582322 |
| 22 | MP0003787_abnormal_imprinting | 2.22636658 |
| 23 | MP0009278_abnormal_bone_marrow | 2.21618475 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.18846645 |
| 25 | MP0002733_abnormal_thermal_nociception | 2.17058045 |
| 26 | MP0001835_abnormal_antigen_presentation | 2.08658232 |
| 27 | MP0004142_abnormal_muscle_tone | 2.07815479 |
| 28 | MP0003724_increased_susceptibility_to | 2.06448833 |
| 29 | MP0001545_abnormal_hematopoietic_system | 2.04003555 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 2.04003555 |
| 31 | MP0006082_CNS_inflammation | 2.03813269 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 2.02389849 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.98953080 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.98107949 |
| 35 | MP0003646_muscle_fatigue | 1.95685202 |
| 36 | MP0002751_abnormal_autonomic_nervous | 1.91228870 |
| 37 | MP0005025_abnormal_response_to | 1.86351147 |
| 38 | MP0001790_abnormal_immune_system | 1.84114381 |
| 39 | MP0005387_immune_system_phenotype | 1.84114381 |
| 40 | MP0001984_abnormal_olfaction | 1.83331702 |
| 41 | MP0003880_abnormal_central_pattern | 1.83046219 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.81363793 |
| 43 | MP0001970_abnormal_pain_threshold | 1.80990701 |
| 44 | MP0002723_abnormal_immune_serum | 1.80470712 |
| 45 | MP0002419_abnormal_innate_immunity | 1.79734857 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.77725425 |
| 47 | MP0000749_muscle_degeneration | 1.76454207 |
| 48 | MP0004957_abnormal_blastocyst_morpholog | 1.76029907 |
| 49 | MP0009764_decreased_sensitivity_to | 1.71472440 |
| 50 | MP0001800_abnormal_humoral_immune | 1.69989313 |
| 51 | MP0002272_abnormal_nervous_system | 1.69497475 |
| 52 | MP0003879_abnormal_hair_cell | 1.68418104 |
| 53 | MP0004133_heterotaxia | 1.68299884 |
| 54 | MP0004270_analgesia | 1.67902714 |
| 55 | MP0002420_abnormal_adaptive_immunity | 1.64763358 |
| 56 | MP0005310_abnormal_salivary_gland | 1.63214906 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.60785911 |
| 58 | MP0003718_maternal_effect | 1.59438359 |
| 59 | MP0001819_abnormal_immune_cell | 1.59073161 |
| 60 | MP0000681_abnormal_thyroid_gland | 1.58556431 |
| 61 | MP0002734_abnormal_mechanical_nocicepti | 1.57651841 |
| 62 | MP0008932_abnormal_embryonic_tissue | 1.55534931 |
| 63 | MP0001529_abnormal_vocalization | 1.54544779 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.53709496 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.51809226 |
| 66 | MP0003279_aneurysm | 1.50848760 |
| 67 | MP0001533_abnormal_skeleton_physiology | 1.49985855 |
| 68 | MP0002254_reproductive_system_inflammat | 1.44740911 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.41000476 |
| 70 | MP0003866_abnormal_defecation | 1.40240435 |
| 71 | MP0001986_abnormal_taste_sensitivity | 1.38256564 |
| 72 | MP0002184_abnormal_innervation | 1.38141103 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.37735850 |
| 74 | MP0004510_myositis | 1.36143669 |
| 75 | MP0003635_abnormal_synaptic_transmissio | 1.36115992 |
| 76 | MP0004147_increased_porphyrin_level | 1.34056456 |
| 77 | MP0000716_abnormal_immune_system | 1.33416730 |
| 78 | MP0002160_abnormal_reproductive_system | 1.32167173 |
| 79 | MP0002822_catalepsy | 1.31636673 |
| 80 | MP0005464_abnormal_platelet_physiology | 1.31494545 |
| 81 | MP0001873_stomach_inflammation | 1.29260905 |
| 82 | MP0000358_abnormal_cell_content/ | 1.29025154 |
| 83 | MP0003075_altered_response_to | 1.28974623 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.28193832 |
| 85 | MP0008469_abnormal_protein_level | 1.27752286 |
| 86 | MP0003122_maternal_imprinting | 1.27505141 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 1.27284567 |
| 88 | MP0002405_respiratory_system_inflammati | 1.27071191 |
| 89 | MP0005410_abnormal_fertilization | 1.24579415 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.24195045 |
| 91 | MP0002064_seizures | 1.23423625 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 1.22837003 |
| 93 | MP0000685_abnormal_immune_system | 1.22376299 |
| 94 | MP0005670_abnormal_white_adipose | 1.17100591 |
| 95 | MP0008260_abnormal_autophagy | 1.16591393 |
| 96 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14797827 |
| 97 | MP0004947_skin_inflammation | 1.14746998 |
| 98 | MP0001905_abnormal_dopamine_level | 1.14740053 |
| 99 | MP0000955_abnormal_spinal_cord | 1.14449221 |
| 100 | MP0005394_taste/olfaction_phenotype | 1.11636439 |
| 101 | MP0005499_abnormal_olfactory_system | 1.11636439 |
| 102 | MP0009333_abnormal_splenocyte_physiolog | 1.10725033 |
| 103 | MP0002429_abnormal_blood_cell | 1.10506330 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 1.10460890 |
| 105 | MP0000604_amyloidosis | 1.09805433 |
| 106 | MP0004811_abnormal_neuron_physiology | 1.07613502 |
| 107 | MP0000343_altered_response_to | 1.05994797 |
| 108 | MP0008007_abnormal_cellular_replicative | 1.05805287 |
| 109 | MP0001919_abnormal_reproductive_system | 1.05303623 |
| 110 | MP0001663_abnormal_digestive_system | 1.03363340 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.01589725 |
| 112 | MP0003077_abnormal_cell_cycle | 1.01339315 |
| 113 | MP0010030_abnormal_orbit_morphology | 1.01218515 |
| 114 | MP0002067_abnormal_sensory_capabilities | 0.99898887 |
| 115 | MP0002933_joint_inflammation | 0.99375917 |
| 116 | MP0001542_abnormal_bone_strength | 0.98101103 |
| 117 | MP0009745_abnormal_behavioral_response | 0.96939060 |
| 118 | MP0005083_abnormal_biliary_tract | 0.96471075 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.96372972 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.92416712 |
| 121 | MP0005165_increased_susceptibility_to | 0.91864779 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.90343205 |
| 123 | MP0008569_lethality_at_weaning | 0.88959252 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.88647471 |
| 125 | MP0005390_skeleton_phenotype | 0.88433411 |
| 126 | MP0006072_abnormal_retinal_apoptosis | 0.88217819 |
| 127 | MP0002163_abnormal_gland_morphology | 0.87991270 |
| 128 | MP0005389_reproductive_system_phenotype | 0.85474888 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.85427263 |
| 130 | MP0002089_abnormal_postnatal_growth/wei | 0.85209731 |
| 131 | MP0008872_abnormal_physiological_respon | 0.84270795 |
| 132 | MP0003111_abnormal_nucleus_morphology | 0.82415308 |
| 133 | MP0005671_abnormal_response_to | 0.81489412 |
| 134 | MP0004130_abnormal_muscle_cell | 0.80601439 |
| 135 | MP0002269_muscular_atrophy | 0.79785596 |
| 136 | MP0009785_altered_susceptibility_to | 0.78501504 |
| 137 | MP0003763_abnormal_thymus_physiology | 0.78350168 |
| 138 | MP0004381_abnormal_hair_follicle | 0.77188878 |
| 139 | MP0005535_abnormal_body_temperature | 0.76909214 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.76739137 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76501490 |
| 142 | MP0003786_premature_aging | 0.76165721 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.75909768 |
| 144 | MP0001188_hyperpigmentation | 0.75344998 |
| 145 | MP0003186_abnormal_redox_activity | 0.74380762 |
| 146 | MP0003191_abnormal_cellular_cholesterol | 0.74018537 |
| 147 | MP0002063_abnormal_learning/memory/cond | 0.73845155 |
| 148 | MP0005166_decreased_susceptibility_to | 0.73738889 |
| 149 | MP0002882_abnormal_neuron_morphology | 0.72733751 |
| 150 | MP0001501_abnormal_sleep_pattern | 0.72540654 |
| 151 | MP0000490_abnormal_crypts_of | 0.71540449 |
| 152 | MP0000313_abnormal_cell_death | 0.70893387 |
| 153 | MP0002396_abnormal_hematopoietic_system | 0.70589531 |
| 154 | MP0002722_abnormal_immune_system | 0.70287928 |
| 155 | MP0010155_abnormal_intestine_physiology | 0.70195042 |
| 156 | MP0009046_muscle_twitch | 0.69073483 |
| 157 | MP0001348_abnormal_lacrimal_gland | 0.68805774 |
| 158 | MP0002752_abnormal_somatic_nervous | 0.67462879 |
| 159 | MP0000689_abnormal_spleen_morphology | 0.66999133 |
| 160 | MP0001764_abnormal_homeostasis | 0.66211390 |
| 161 | MP0002066_abnormal_motor_capabilities/c | 0.65837102 |
| 162 | MP0003315_abnormal_perineum_morphology | 0.65362467 |
| 163 | MP0000747_muscle_weakness | 0.65292622 |
| 164 | MP0004233_abnormal_muscle_weight | 0.65278256 |
| 165 | MP0002398_abnormal_bone_marrow | 0.65056469 |
| 166 | MP0000703_abnormal_thymus_morphology | 0.64928916 |
| 167 | MP0005381_digestive/alimentary_phenotyp | 0.64803898 |
| 168 | MP0002693_abnormal_pancreas_physiology | 0.64180714 |
| 169 | MP0002229_neurodegeneration | 0.63690762 |
| 170 | MP0005423_abnormal_somatic_nervous | 0.63494095 |
| 171 | MP0003121_genomic_imprinting | 0.62944904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 5.29543038 |
| 2 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.75230732 |
| 3 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.75230732 |
| 4 | Mitochondrial inheritance (HP:0001427) | 4.73822306 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.66299525 |
| 6 | Myokymia (HP:0002411) | 4.61990225 |
| 7 | Hepatic necrosis (HP:0002605) | 4.59476056 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 4.39183576 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.38464476 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.38464476 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.38464476 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.16020167 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 4.15175458 |
| 14 | Increased CSF lactate (HP:0002490) | 4.03059680 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.78993731 |
| 16 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.71909161 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.63418143 |
| 18 | Vacuolated lymphocytes (HP:0001922) | 3.60513063 |
| 19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.52533958 |
| 20 | Emotional lability (HP:0000712) | 3.50417961 |
| 21 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.49971410 |
| 22 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.49971410 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.49971410 |
| 24 | Increased intramyocellular lipid droplets (HP:0012240) | 3.37459514 |
| 25 | Acute encephalopathy (HP:0006846) | 3.34097316 |
| 26 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.33862227 |
| 27 | Increased serum lactate (HP:0002151) | 3.32253041 |
| 28 | Delusions (HP:0000746) | 3.27520335 |
| 29 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.27439123 |
| 30 | Dysostosis multiplex (HP:0000943) | 3.26394844 |
| 31 | Aplastic anemia (HP:0001915) | 3.24702218 |
| 32 | Hyperthyroidism (HP:0000836) | 3.11783336 |
| 33 | Congenital stationary night blindness (HP:0007642) | 3.10361851 |
| 34 | Macrocytic anemia (HP:0001972) | 3.09403848 |
| 35 | Increased muscle lipid content (HP:0009058) | 3.06375480 |
| 36 | Increased hepatocellular lipid droplets (HP:0006565) | 3.04613976 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.03357316 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03357316 |
| 39 | Lactic acidosis (HP:0003128) | 3.01474511 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.99465606 |
| 41 | Progressive macrocephaly (HP:0004481) | 2.98991484 |
| 42 | Visual hallucinations (HP:0002367) | 2.96113701 |
| 43 | Reticulocytopenia (HP:0001896) | 2.90331628 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.89982840 |
| 45 | Abnormality of macular pigmentation (HP:0008002) | 2.88072083 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.86154620 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.84803878 |
| 48 | Obstructive lung disease (HP:0006536) | 2.84803878 |
| 49 | Respiratory failure (HP:0002878) | 2.83113402 |
| 50 | Unsteady gait (HP:0002317) | 2.80260899 |
| 51 | Microretrognathia (HP:0000308) | 2.75838498 |
| 52 | Severe visual impairment (HP:0001141) | 2.73569242 |
| 53 | Prolonged neonatal jaundice (HP:0006579) | 2.66035722 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 2.64688269 |
| 55 | CNS demyelination (HP:0007305) | 2.63468854 |
| 56 | Exercise intolerance (HP:0003546) | 2.61198130 |
| 57 | Split foot (HP:0001839) | 2.57806097 |
| 58 | Retinal atrophy (HP:0001105) | 2.53884480 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 2.50673921 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.49652331 |
| 61 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.48350674 |
| 62 | Hypercortisolism (HP:0001578) | 2.47950964 |
| 63 | Exertional dyspnea (HP:0002875) | 2.47792706 |
| 64 | Renal Fanconi syndrome (HP:0001994) | 2.44500972 |
| 65 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.42050074 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.37444197 |
| 67 | Pallor (HP:0000980) | 2.36244060 |
| 68 | Protruding tongue (HP:0010808) | 2.35480499 |
| 69 | Abnormality of magnesium homeostasis (HP:0004921) | 2.33549334 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.32749087 |
| 71 | Pustule (HP:0200039) | 2.32013153 |
| 72 | Axonal loss (HP:0003447) | 2.31178736 |
| 73 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30762487 |
| 74 | Mesangial abnormality (HP:0001966) | 2.28990654 |
| 75 | Polyphagia (HP:0002591) | 2.28486807 |
| 76 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26678510 |
| 77 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26678510 |
| 78 | Abnormality of alanine metabolism (HP:0010916) | 2.26537098 |
| 79 | Hyperalaninemia (HP:0003348) | 2.26537098 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26537098 |
| 81 | Purpura (HP:0000979) | 2.25718009 |
| 82 | Macular degeneration (HP:0000608) | 2.25530235 |
| 83 | Poor suck (HP:0002033) | 2.22701625 |
| 84 | Recurrent fungal infections (HP:0002841) | 2.21508438 |
| 85 | Increased serum ferritin (HP:0003281) | 2.21179448 |
| 86 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18935088 |
| 87 | Postnatal microcephaly (HP:0005484) | 2.18396202 |
| 88 | Loss of speech (HP:0002371) | 2.17435175 |
| 89 | Joint stiffness (HP:0001387) | 2.16863970 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 2.16302716 |
| 91 | Abnormal protein glycosylation (HP:0012346) | 2.16038488 |
| 92 | Abnormal glycosylation (HP:0012345) | 2.16038488 |
| 93 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.16038488 |
| 94 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.16038488 |
| 95 | Hyperparathyroidism (HP:0000843) | 2.15970580 |
| 96 | Pheochromocytoma (HP:0002666) | 2.15465731 |
| 97 | Petechiae (HP:0000967) | 2.12056798 |
| 98 | Hematochezia (HP:0002573) | 2.07612814 |
| 99 | Coxa valga (HP:0002673) | 2.06513627 |
| 100 | Large eyes (HP:0001090) | 2.06260885 |
| 101 | Abnormality of dental color (HP:0011073) | 2.03441773 |
| 102 | Failure to thrive in infancy (HP:0001531) | 2.00125297 |
| 103 | Limb dystonia (HP:0002451) | 2.00115127 |
| 104 | Myositis (HP:0100614) | 1.99317421 |
| 105 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97993353 |
| 106 | Oral leukoplakia (HP:0002745) | 1.97649158 |
| 107 | Optic disc pallor (HP:0000543) | 1.97540609 |
| 108 | Respiratory difficulties (HP:0002880) | 1.96182978 |
| 109 | Premature loss of primary teeth (HP:0006323) | 1.95501458 |
| 110 | Abolished electroretinogram (ERG) (HP:0000550) | 1.93169812 |
| 111 | Chronic hepatic failure (HP:0100626) | 1.91770592 |
| 112 | Reduced antithrombin III activity (HP:0001976) | 1.91685033 |
| 113 | Leukodystrophy (HP:0002415) | 1.91126459 |
| 114 | Cerebral edema (HP:0002181) | 1.90666126 |
| 115 | Gastrointestinal infarctions (HP:0005244) | 1.90519614 |
| 116 | Cerebral palsy (HP:0100021) | 1.90391460 |
| 117 | Cutaneous melanoma (HP:0012056) | 1.88791224 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.88255572 |
| 119 | Late onset (HP:0003584) | 1.88218902 |
| 120 | Vertebral compression fractures (HP:0002953) | 1.87689823 |
| 121 | Ankle clonus (HP:0011448) | 1.87654108 |
| 122 | Stomatitis (HP:0010280) | 1.85107433 |
| 123 | Hydroureter (HP:0000072) | 1.85059365 |
| 124 | Agammaglobulinemia (HP:0004432) | 1.83709161 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.83309279 |
| 126 | Oligomenorrhea (HP:0000876) | 1.82523785 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81145727 |
| 128 | Progressive microcephaly (HP:0000253) | 1.81053370 |
| 129 | Abnormality of the columella (HP:0009929) | 1.80380305 |
| 130 | Stridor (HP:0010307) | 1.80232438 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 1.80020740 |
| 132 | Focal dystonia (HP:0004373) | 1.79925970 |
| 133 | Adactyly (HP:0009776) | 1.78544910 |
| 134 | Hyperphosphaturia (HP:0003109) | 1.77833783 |
| 135 | Retinal dysplasia (HP:0007973) | 1.77293377 |
| 136 | Trismus (HP:0000211) | 1.76589077 |
| 137 | Amblyopia (HP:0000646) | 1.75564680 |
| 138 | Thrombocytosis (HP:0001894) | 1.75435075 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 1.75114154 |
| 140 | Peripheral hypomyelination (HP:0007182) | 1.73306467 |
| 141 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.73305460 |
| 142 | Short femoral neck (HP:0100864) | 1.72783479 |
| 143 | Thoracolumbar scoliosis (HP:0002944) | 1.72546549 |
| 144 | Growth hormone excess (HP:0000845) | 1.72053399 |
| 145 | Limb-girdle muscle atrophy (HP:0003797) | 1.71676799 |
| 146 | Type II lissencephaly (HP:0007260) | 1.71602448 |
| 147 | Opisthotonus (HP:0002179) | 1.71578538 |
| 148 | Broad distal phalanx of finger (HP:0009836) | 1.71170322 |
| 149 | Recurrent abscess formation (HP:0002722) | 1.70001750 |
| 150 | Menstrual irregularities (HP:0000858) | 1.69852836 |
| 151 | Asymmetric septal hypertrophy (HP:0001670) | 1.67869975 |
| 152 | Recurrent skin infections (HP:0001581) | 1.67407334 |
| 153 | Progressive external ophthalmoplegia (HP:0000590) | 1.66557207 |
| 154 | Craniofacial dystonia (HP:0012179) | 1.66067323 |
| 155 | Abnormality of the aortic arch (HP:0012303) | 1.65993088 |
| 156 | Progressive muscle weakness (HP:0003323) | 1.65889715 |
| 157 | Broad face (HP:0000283) | 1.65756519 |
| 158 | Restlessness (HP:0000711) | 1.65297040 |
| 159 | Agitation (HP:0000713) | 1.64175368 |
| 160 | Death in infancy (HP:0001522) | 1.63760591 |
| 161 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.62782757 |
| 162 | Anxiety (HP:0000739) | 1.61586103 |
| 163 | CNS hypomyelination (HP:0003429) | 1.61564415 |
| 164 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.61171608 |
| 165 | Panhypogammaglobulinemia (HP:0003139) | 1.60604778 |
| 166 | Pulmonary infiltrates (HP:0002113) | 1.60236072 |
| 167 | External ophthalmoplegia (HP:0000544) | 1.59990572 |
| 168 | Abnormality of the thoracic spine (HP:0100711) | 1.58925442 |
| 169 | Muscle fiber atrophy (HP:0100295) | 1.58900916 |
| 170 | Progressive visual loss (HP:0000529) | 1.58817104 |
| 171 | Hypertensive crisis (HP:0100735) | 1.58487519 |
| 172 | Abnormality of pain sensation (HP:0010832) | 1.57491544 |
| 173 | Impaired pain sensation (HP:0007328) | 1.57491544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.39946566 |
| 2 | STK16 | 4.19745075 |
| 3 | TESK2 | 3.55359113 |
| 4 | ARAF | 3.33082220 |
| 5 | NME2 | 2.90222898 |
| 6 | CDK19 | 2.85861526 |
| 7 | MAP4K2 | 2.72511479 |
| 8 | MAP3K11 | 2.68028203 |
| 9 | MAP3K10 | 2.63271849 |
| 10 | KDR | 2.63268948 |
| 11 | BRAF | 2.38279892 |
| 12 | IRAK3 | 2.34672358 |
| 13 | CAMKK2 | 2.32879054 |
| 14 | TLK1 | 2.17647712 |
| 15 | LIMK1 | 2.16558895 |
| 16 | PIM2 | 2.09542263 |
| 17 | EIF2AK1 | 2.02488212 |
| 18 | TESK1 | 1.99382264 |
| 19 | MAP3K12 | 1.97302543 |
| 20 | NME1 | 1.96841146 |
| 21 | FRK | 1.85083018 |
| 22 | SCYL2 | 1.72807344 |
| 23 | BCKDK | 1.62114557 |
| 24 | TXK | 1.55578837 |
| 25 | MINK1 | 1.47202126 |
| 26 | IKBKB | 1.40507540 |
| 27 | FES | 1.40078807 |
| 28 | DYRK3 | 1.39374612 |
| 29 | ERN1 | 1.36914740 |
| 30 | WEE1 | 1.36392938 |
| 31 | BLK | 1.33851412 |
| 32 | MAP3K9 | 1.33550393 |
| 33 | IRAK4 | 1.32364164 |
| 34 | PRKD2 | 1.23565749 |
| 35 | AURKA | 1.23507602 |
| 36 | TAOK1 | 1.21889242 |
| 37 | MAP4K1 | 1.19040831 |
| 38 | SIK2 | 1.16460976 |
| 39 | ZAP70 | 1.15024902 |
| 40 | MAP2K2 | 1.14604001 |
| 41 | VRK2 | 1.13900016 |
| 42 | PAK4 | 1.11807320 |
| 43 | DYRK2 | 1.09690169 |
| 44 | UHMK1 | 1.08397463 |
| 45 | CAMKK1 | 1.06335744 |
| 46 | ILK | 1.04404057 |
| 47 | PINK1 | 1.03446209 |
| 48 | KIT | 1.02716155 |
| 49 | DYRK1B | 1.00967629 |
| 50 | MAP3K4 | 1.00532671 |
| 51 | RPS6KL1 | 1.00474716 |
| 52 | RPS6KC1 | 1.00474716 |
| 53 | JAK3 | 0.99821816 |
| 54 | DAPK3 | 0.99702801 |
| 55 | RPS6KA6 | 0.99543035 |
| 56 | RAF1 | 0.99344402 |
| 57 | RPS6KA2 | 0.98621932 |
| 58 | MATK | 0.97731877 |
| 59 | GRK7 | 0.97311417 |
| 60 | SYK | 0.97216419 |
| 61 | SMG1 | 0.95798235 |
| 62 | MUSK | 0.93273713 |
| 63 | MAP2K6 | 0.91777532 |
| 64 | ITK | 0.91418444 |
| 65 | PAK1 | 0.89960425 |
| 66 | CDK14 | 0.88076066 |
| 67 | BRSK1 | 0.87371048 |
| 68 | MARK3 | 0.85688897 |
| 69 | EIF2AK3 | 0.85502104 |
| 70 | VRK1 | 0.82771091 |
| 71 | CDK11A | 0.80615555 |
| 72 | PRKCI | 0.79266169 |
| 73 | ABL2 | 0.77429421 |
| 74 | FLT3 | 0.77046389 |
| 75 | CSNK1A1L | 0.76645364 |
| 76 | BTK | 0.75830351 |
| 77 | DAPK1 | 0.75266779 |
| 78 | CSNK1G2 | 0.75080491 |
| 79 | MAP3K14 | 0.74957649 |
| 80 | PAK6 | 0.74701468 |
| 81 | TAOK2 | 0.74449393 |
| 82 | BRSK2 | 0.73427963 |
| 83 | CDK7 | 0.73281088 |
| 84 | CDK8 | 0.72681092 |
| 85 | CSF1R | 0.71557281 |
| 86 | NEK1 | 0.70812163 |
| 87 | TNK2 | 0.70703450 |
| 88 | CDK18 | 0.70387947 |
| 89 | LYN | 0.69547416 |
| 90 | KSR2 | 0.69008297 |
| 91 | RIPK4 | 0.68618577 |
| 92 | SRPK1 | 0.68372387 |
| 93 | MAPKAPK3 | 0.67020629 |
| 94 | CDK15 | 0.66973580 |
| 95 | IRAK1 | 0.64403336 |
| 96 | TIE1 | 0.63916712 |
| 97 | CSNK1G3 | 0.63651938 |
| 98 | MYLK | 0.63383903 |
| 99 | PASK | 0.63379010 |
| 100 | PKN1 | 0.63078658 |
| 101 | HCK | 0.59835501 |
| 102 | CSK | 0.59376558 |
| 103 | LRRK2 | 0.58509828 |
| 104 | CHUK | 0.56195216 |
| 105 | LCK | 0.55725212 |
| 106 | PHKG1 | 0.55593740 |
| 107 | PHKG2 | 0.55593740 |
| 108 | MAPK11 | 0.54970394 |
| 109 | CAMK2G | 0.54883707 |
| 110 | MARK2 | 0.54461126 |
| 111 | STK11 | 0.53169556 |
| 112 | NTRK1 | 0.52097020 |
| 113 | IKBKE | 0.51961827 |
| 114 | GRK6 | 0.51695074 |
| 115 | LATS2 | 0.50544806 |
| 116 | RPS6KA4 | 0.50095653 |
| 117 | PDPK1 | 0.49098260 |
| 118 | PIM1 | 0.48873507 |
| 119 | NTRK3 | 0.48672860 |
| 120 | MAP3K8 | 0.48222772 |
| 121 | CDC42BPA | 0.47745072 |
| 122 | TRIB3 | 0.47509561 |
| 123 | MAP2K4 | 0.47482335 |
| 124 | TAOK3 | 0.46734790 |
| 125 | TBK1 | 0.46401834 |
| 126 | CAMK1 | 0.45847742 |
| 127 | ADRBK1 | 0.45478799 |
| 128 | MAP2K3 | 0.45189850 |
| 129 | MARK1 | 0.45101050 |
| 130 | DDR2 | 0.44809835 |
| 131 | MAP3K1 | 0.43947284 |
| 132 | PRKD3 | 0.43652629 |
| 133 | PDK1 | 0.43640124 |
| 134 | MAPK4 | 0.42928450 |
| 135 | PRKCG | 0.42719278 |
| 136 | PRKCQ | 0.42568447 |
| 137 | MAP2K7 | 0.41886664 |
| 138 | CSNK1G1 | 0.41791926 |
| 139 | PRPF4B | 0.41487093 |
| 140 | PRKG2 | 0.40396624 |
| 141 | CDK4 | 0.39074052 |
| 142 | IRAK2 | 0.38911237 |
| 143 | CAMK2B | 0.36897363 |
| 144 | MAPK13 | 0.36715055 |
| 145 | GRK5 | 0.34724377 |
| 146 | ADRBK2 | 0.34521227 |
| 147 | CSNK2A1 | 0.33741710 |
| 148 | SIK3 | 0.33066588 |
| 149 | PLK1 | 0.32821578 |
| 150 | DAPK2 | 0.32819283 |
| 151 | HIPK2 | 0.32315678 |
| 152 | CSNK2A2 | 0.30026986 |
| 153 | CDK5 | 0.28820157 |
| 154 | RPS6KA5 | 0.27683860 |
| 155 | MAP2K1 | 0.27595915 |
| 156 | ACVR1B | 0.26980576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.47627865 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.55684534 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.05750309 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.90042740 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.73569798 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.01692794 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.82063369 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67694600 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.65608589 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.62153782 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.58898735 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.57261581 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53824935 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 2.50108243 |
| 15 | Asthma_Homo sapiens_hsa05310 | 2.49572700 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41566484 |
| 17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.38773793 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.14543888 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.13402796 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 2.06931077 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.98272250 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.86200109 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.82861310 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78834633 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76021793 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71383523 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.70694721 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.67192160 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.61499917 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.59547443 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.57915213 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.56808538 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54772321 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.50084531 |
| 35 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.49602567 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49201053 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.48037252 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45273571 |
| 39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.43076369 |
| 40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.39730691 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39186925 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 1.35288538 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.31357622 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30129298 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29221971 |
| 46 | RNA transport_Homo sapiens_hsa03013 | 1.23422656 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19795903 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13936113 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12027110 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.11251258 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.09244355 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.05806690 |
| 53 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.04974051 |
| 54 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00438767 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 1.00064136 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97426011 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.96637345 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.95964495 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95208554 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94596670 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91209722 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89064600 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89025735 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88883492 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.87879138 |
| 66 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87580609 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.87266530 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86834598 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86274551 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86156418 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84392586 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83675480 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83138610 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.82732307 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81343031 |
| 76 | Cell cycle_Homo sapiens_hsa04110 | 0.80852036 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.80359640 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77713213 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.76762847 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76471512 |
| 81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75196695 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72431205 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71958877 |
| 84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70764292 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69325117 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69299576 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69084419 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.67936923 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67000676 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66204276 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.65615866 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64572992 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64395950 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63718867 |
| 95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63605040 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61696628 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.61139830 |
| 98 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60751964 |
| 99 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60318581 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60136493 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59090271 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58779884 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58689596 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58165579 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58098585 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56579166 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56297608 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55812655 |
| 109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55233561 |
| 110 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53829446 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53652973 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.53645736 |
| 113 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52897000 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.52523824 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52483545 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51467568 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50307447 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49702811 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47963623 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47852389 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47541405 |
| 122 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45766201 |
| 123 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45446426 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43602625 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.43546257 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.42990690 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40363107 |
| 128 | Insulin secretion_Homo sapiens_hsa04911 | 0.40145535 |
| 129 | Other glycan degradation_Homo sapiens_hsa00511 | 0.39910185 |
| 130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39828276 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38845725 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36953933 |
| 133 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35813371 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.35691920 |
| 135 | ABC transporters_Homo sapiens_hsa02010 | 0.34461518 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.34401255 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33158426 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30771586 |
| 139 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30555007 |
| 140 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30396876 |
| 141 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30039862 |
| 142 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29242317 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.25590275 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24945417 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.24638588 |
| 146 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24066786 |
| 147 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23117146 |
| 148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22486420 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.21923779 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21453952 |
| 151 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18538245 |
| 152 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18285915 |
| 153 | Morphine addiction_Homo sapiens_hsa05032 | 0.17535697 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17428339 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.17393147 |
| 156 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17125079 |
| 157 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.16273388 |
| 158 | Lysosome_Homo sapiens_hsa04142 | 0.15954160 |
| 159 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15941225 |
| 160 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.14935045 |
| 161 | Taste transduction_Homo sapiens_hsa04742 | 0.12646652 |
| 162 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.10157615 |
| 163 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09533155 |

